Skip to main content

Table 1 Patient demographics

From: Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study

 

Early group (n = 851)

Normal group (n = 586)

SMD

Early group (n = 861)

Normal group (n = 558)

SMD

Age (median [IQR])

69.1 [58.0, 78.8]

67.0 [56.7, 78.3]

0.048

67.9 [56.8, 78.0]

67.67 [57.27, 79.24]

0.078

Male (%)

522 (61.3)

327 (55.8)

0.113

508 (59.0)

327 (58.6)

0.009

Weight (median [IQR])

81.0 [69.6, 97.5]

78.8 [65.6, 97.5]

0.076

80.6 [68.7, 96.8]

78.20 [65.09, 97.16]

0.070

Race (%)

  

0.165

  

0.033

 White

19 (2.2)

23 (3.9)

 

26 (3.1)

18 (3.2)

 

 Black

61 (7.2)

62 (10.6)

 

72 (8.4)

48 (8.7)

 

 Hispanic

30 (3.5)

21 (3.6)

 

31 (3.6)

21 (3.7)

 

 Asian

176 (20.7)

123 (21.0)

 

185 (21.5)

125 (22.4)

 

 Other

565 (66.4)

357 (60.9)

 

547 (63.5)

346 (62.0)

 

Admission type (%)

  

0.200

  

0.086

 Elective

192 (22.6)

93 (15.9)

 

168 (19.5)

94 (16.7)

 

 Emergency

449 (52.8)

362 (61.8)

 

491 (57.1)

341 (61.0)

 

 Urgent

210 (24.7)

131 (22.4)

 

202 (23.4)

124 (22.3)

 

First care unit (%)

  

0.586

  

0.095

 Cardiac ICU

281 (33.0)

63 (10.8)

 

203 (23.6)

110 (19.7)

 

 Medical/Surgical ICU

382 (44.9)

391 (66.7)

 

465 (54.1)

318 (56.9)

 

 Neuro ICU

6 (0.7)

8 (1.4)

 

9 (1.0)

6 (1.1)

 

 TSICU

182 (21.4)

124 (21.2)

 

184 (21.4)

124 (22.3)

 

Time from hypotension episode to NE use (minute, median [IQR])

3.0 [0.0, 24.5]

13.0 [0.0, 147.8]

0.174

5.0 [0.0, 35.7]

10.00 [0.00, 105.80]

0.02

Maximum NEQ dose (median [IQR])

0.64 [0.37, 1.15]

1.06 [0.82, 1.35]

0.201

0.77 [0.4, 1.3]

1.02 [0.80, 1.30]

0.036

Scoring system

      

 SOFA (median [IQR])

12 [9, 14]

13 [11, 16]

0.372

12 [10, 15]

12.00 [10.00, 15.00]

0.029

 Charlson comorbidity index (median [IQR])

6 [4, 8]

6 [5, 8]

0.057

6 [4, 8]

6.00 [5.00, 8.00]

0.024

Intervention

      

 Antibiotic use < 1 h from sepsis (%)

334 (39.2)

265 (45.2)

0.121

356 (41.3)

238 (42.5)

0.025

 RRT (%)

128 (15.0)

131 (22.4)

0.188

157 (18.2)

103 (18.4)

0.004

 MV (%)

685 (80.5)

477 (81.4)

0.023

697 (81.0)

457 (81.8)

0.022

Comorbidity

      

 Endocarditis (%)

18 (2.1)

13 (2.2)

0.007

20 (2.4)

15 (2.7)

0.024

 CHF (%)

331 (38.9)

186 (31.7)

0.15

312 (36.2)

192 (34.4)

0.037

 AFIB (%)

364 (42.8)

181 (30.9)

0.248

323 (37.5)

1978 (35.4)

0.044

 Renal disease (%)

219 (25.7)

159 (27.1)

0.032

219 (25.5)

149 (26.6)

0.026

 Liver disease (%)

95 (11.2)

84 (14.3)

0.095

116 (13.5)

73 (13.1)

0.013

 COPD (%)

144 (16.9)

81 (13.8)

0.086

141 (16.3)

81 (14.5)

0.051

 CAD (%)

287 (33.7)

123 (21.0)

0.289

240 (27.8)

144 (25.7)

0.048

 Stroke (%)

44 (5.2)

26 (4.4)

0.034

42 (4.8)

37 (6.2)

0.059

 Malignancy (%)

149 (17.5)

146 (24.9)

0.182

177 (20.6)

121 (21.6)

0.025

 Respiratory failure (%)

389 (45.7)

296 (50.5)

0.096

420 (48.8)

282 (50.6)

0.034

 ARDS (%)

72 (8.5)

60 (10.2)

0.061

76 (8.8)

58 (10.3)

0.051

 Pneumonia (%)

286 (33.6)

230 (39.2)

0.117

313 (36.4)

214 (38.4)

0.041

Vital sign

      

 Heart rate (median [IQR])

92.85 [80.14, 107.10]

97.35 [84.15, 109.53]

0.175

96.38 [81.55, 108.91]

96.66 [84.48, 108.01]

0.044

 Systolic BP (median [IQR])

103.79 [97.78, 110.40]

101.98 [95.86, 108.14]

0.177

102.51 [96.67, 109.60]

102.24 [96.26, 108.25]

0.034

 Diastolic BP (median [IQR])

55.98 [50.56, 61.48]

55.39 [49.59, 60.69]

0.052

55.81 [50.38, 61.47]

55.84 [49.96, 60.79]

0.004

 MAP (median [IQR])

70.08 [65.91, 74.40]

68.99 [64.20, 73.98]

0.143

69.61 [65.25, 74.17]

69.40 [64.79, 74.51]

0.005

 Respiratory rate (median [IQR])

21.00 [18.23, 24.48]

23.08 [19.79, 26.06]

0.364

21.83 [18.88, 25.38]

22.31 [19.38, 25.55]

0.064

 Temperature (median [IQR])

36.84 [36.50, 37.22]

36.85 [36.45, 37.36]

0.037

36.84 [36.45, 37.28]

36.82 [36.43, 37.34]

0.011

 Oxygen saturation (median [IQR])

97.17 [95.28, 98.43]

96.43 [94.21, 98.07]

0.145

96.95 [94.84, 98.30]

96.70 [94.50, 98.20]

0.037

Laboratory indicator

      

 WBC (median [IQR])

14.45 [9.90, 20.02]

15.37 [8.87, 21.85]

0.086

14.55 [9.60, 20.68]

15.49 [9.10, 21.85]

0.041

 Hemoglobin (median [IQR])

9.80 [8.84, 11.23]

9.96 [8.70, 11.58]

0.036

9.80 [8.75, 11.35]

9.99 [8.77, 11.62]

0.049

 BUN (median [IQR])

29.40 [19.00, 45.58]

37.33 [23.04, 55.85]

0.261

31.90 [20.00, 50.00]

34.00 [21.00, 53.33]

0.037

 PT (median [IQR])

16.82 [14.38, 21.75]

18.30 [14.65, 24.71]

0.181

17.25 [14.60, 23.13]

17.71 [14.45, 23.44]

0.029

 APTT (median [IQR])

37.20 [31.19, 48.52]

40.22 [32.34, 55.06]

0.158

38.26 [31.45, 51.24]

39.87 [31.80, 53.96]

0.038

 INR (median [IQR])

1.53 [1.30, 2.03]

1.69 [1.35, 2.30]

0.167

1.60 [1.30, 2.15]

1.62 [1.30, 2.15]

0.027

 Bicarbonate (median [IQR])

19.50 [16.00, 22.50]

17.17 [14.00, 20.58]

0.400

18.50 [15.00, 21.67]

18.00 [15.00, 21.50]

0.034

 Anion gap (median [IQR])

16.25 [13.00, 20.17]

18.82 [15.75, 23.32]

0.432

17.20 [14.00, 21.50]

17.60 [14.74, 22.00]

0.043

 Sodium (median [IQR])

138.00 [135.00, 141.00]

137.50 [134.00, 140.50]

0.126

137.80 [134.50, 140.80]

137.64 [134.00, 140.67]

0.008

 Chloride (median [IQR])

105.00 [100.50, 109.00]

103.33 [98.00, 107.75]

0.216

104.33 [99.50, 108.50]

104.00 [99.00, 108.33]

0.019

 Potassium (median [IQR])

4.33 [3.95, 4.75]

4.40 [4.00, 5.04]

0.193

4.37 [3.95, 4.86]

4.34 [3.95, 4.93]

0.001

 Lactate (median [IQR])

3.13 [1.90, 5.29]

3.96 [2.40, 6.64]

0.252

3.35 [2.00, 5.92]

3.66 [2.23, 6.11]

0.015

  1. SMD standardized mean difference, IQR inter quartile range, ICU intensive care unit, NEQ norepinephrine-equivalent doses, SOFA sequential organ failure assessment, RRT renal replacement therapy, MV mechanical ventilation, CHF congestive heart failure, AFIB atrial fibrillation, COPD chronic obstructive pulmonary disease, CAD coronary atherothrombotic disease; ARDS, acute respiratory distress syndrome, BP blood pressure, MAP mean artery pressure, WBC white blood cell; BUN blood urea nitrogen, PT prothrombin time, APTT activated partial thromboplastin time, INR international normalized ratio